Autoimmunity is the immune system over activity that begin producing antibodies to attack the body’s own tissues instead of fighting infections. The most common evidence of autoimmune response post TBI was reported as hypothalamic-pituitary autoimmunity (APA){Guaraldi:2015bc}. Recently, autoimmunity trigged by other released GFAP, MBP, S100b and glutamate receptor have been observed in human TBI{Cox:2006wo, Sorokina:2009ud, Zhang:2014ju}. Although an increasing evidences show post-TBI autoimmunity by detecting some brain specific autoantibodies in preclinical and clinical studies, it is still a less explored area of autoimmunity. In this review, we first discuss how the autoimmunity is triggered in TBI and summarize the current self-antigens. We further focus on the TBI-generated brain specific antigens based on animal research and clinical studies as well as the possibility strategy of biofluid-based TBI diagnosis. Last we also discuss the characteristics of these autoantibodies post
Autoimmunity is the immune system over activity that begin producing antibodies to attack the body’s own tissues instead of fighting infections. The most common evidence of autoimmune response post TBI was reported as hypothalamic-pituitary autoimmunity (APA){Guaraldi:2015bc}. Recently, autoimmunity trigged by other released GFAP, MBP, S100b and glutamate receptor have been observed in human TBI{Cox:2006wo, Sorokina:2009ud, Zhang:2014ju}. Although an increasing evidences show post-TBI autoimmunity by detecting some brain specific autoantibodies in preclinical and clinical studies, it is still a less explored area of autoimmunity. In this review, we first discuss how the autoimmunity is triggered in TBI and summarize the current self-antigens. We further focus on the TBI-generated brain specific antigens based on animal research and clinical studies as well as the possibility strategy of biofluid-based TBI diagnosis. Last we also discuss the characteristics of these autoantibodies post